Table 2.
Hyperthyroidism N = 92,783 | |||
---|---|---|---|
Graves’ disease N (%) | Struma nodosa toxica N (%) | Other hyperthyroidism N (%) | |
Total | 38,508 (100.0) | 34,703 (100.0) | 19,572 (100.0) |
Age (years) | |||
0–29 | 4149 (10.8) | 922 (2.7) | 1481 (7.6) |
30–49 | 11,649 (30.3) | 5844 (16.8) | 4014 (20.5) |
50–69 | 13,120 (34.1) | 14,897 (42.9) | 6473 (33.1) |
70+ | 9590 (24.9) | 13,040 (37.6) | 7604 (38.9) |
Sex | |||
Women | 31,897 (82.8) | 29,166 (84.0) | 15,501 (79.2) |
Men | 6611 (17.2) | 5537 (16.0) | 4071 (20.8) |
Year of diagnosis | |||
1978–1982 | 3082 (8.0) | 4932 (14.2) | 1 (<0.1) |
1983–1987 | 2353 (6.1) | 4475 (12.9) | 0 (0.0) |
1988–1992 | 2601 (6.8) | 5022 (14.4) | 105 (0.5) |
1993–1997 | 6385 (16.6) | 4993 (14.4) | 2806 (14.3) |
1998–2002 | 8649 (22.5) | 5395 (15.6) | 4457 (22.8) |
2003–2007 | 8975 (23.3) | 4765 (13.7) | 4718 (24.1) |
2008–2013 | 6463 (16.8) | 5121 (14.8) | 7485 (38.2) |
Patient type | |||
Inpatient | 17,730 (46.0) | 18,240 (52.6) | 7872 (40.2) |
Half-day patient | 1686 (4.4) | 1680 (4.8) | 489 (2.5) |
Outpatient | 19,092 (49.6) | 14,783 (42.6) | 11,211 (57.3) |
Comorbidity | |||
Alcoholism | 583 (1.5) | 318 (0.9) | 437 (2.2) |
Autoimmune disease | 2771 (7.2) | 2270 (6.5) | 1929 (9.9) |
Pancreatitis | 214 (0.6) | 186 (0.5) | 193 (1.0) |
COPD | 2830 (7.4) | 2653 (7.7) | 2281 (11.7) |
IBD | 381 (1.0) | 292 (0.8) | 262 (1.3) |
Colitis ulcerosa | 259 (0.7) | 183 (0.5) | 177 (0.9) |
Crohn’s disease | 138 (0.4) | 102 (0.3) | 98 (0.5) |
Diabetes | 2226 (5.8) | 2321 (6.7) | 1555 (8.0) |
Obesity | 1194 (3.1) | 965 (2.8) | 910 (4.7) |
HIV | 7 (<0.1) | 5 (<0.1) | 10 (0.1) |
GI bleeding | 273 (0.7) | 223 (0.6) | 268 (1.4) |
Charlson Comorbidity Index score | |||
Low (0) | 30,187 (78.4) | 26,670 (76.9) | 12,995 (66.4) |
Medium (1–2) | 7210 (18.7) | 7061 (20.3) | 5392 (27.6) |
High (≥3) | 1111 (2.9) | 972 (2.8) | 1185 (6.1) |
COPD, chronic obstructive pulmonary disease; GI, gastrointestinal; HIV, human immunodeficiency virus; IBD, inflammatory bowel disease.